A fluorescence-microscopic and cytofluorometric system for monitoring the turnover of the autophagic substrate p62/SQSTM1

被引:46
|
作者
Ben Younes, Amena [1 ,2 ,3 ]
Tajeddine, Nicolas [1 ,2 ,3 ]
Tailler, Maximilien [1 ,2 ,3 ]
Malik, Shoaib Ahmad [1 ,2 ,3 ]
Shen, Shensi [1 ,2 ,3 ]
Metivier, Didier [1 ,2 ,3 ]
Kepp, Oliver [1 ,2 ,3 ]
Vitale, Ilio [1 ,2 ,3 ]
Maiuri, Maria Chiara [1 ,2 ,3 ]
Kroemer, Guido [1 ,2 ,4 ,5 ,6 ]
机构
[1] INSERM, Villejuif, France
[2] Inst Gustave Roussy, Villejuif, France
[3] Univ Paris 11, Fac Med, Paris, France
[4] Ctr Rech Cordeliers, Paris, France
[5] Hop Europeen Georges Pompidou, AP HP, Paris, France
[6] Univ Paris 05, Paris, France
关键词
autophagic flux; fluorescent assay; high-throughput assay; macroautophagy; protein turnover; BINDING PROTEIN P62; CANCER; DEGRADATION; EXPRESSION;
D O I
10.4161/auto.7.8.15538
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Autophagic flux can be measured by determining the declining abundance of autophagic substrates such as sequestosome 1 (SQSTM1, better known as p62), which is sequestered in autophagosomes upon its direct interaction with LC3. However, the total amount of p62 results from two opposed processes, namely its synthesis (which can be modulated by some cellular stressors including autophagy inducers) and its degradation. To avoid this problem, we generated a stable cell line expressing a chimeric protein composed of p62 and the HaloTag® protein, which serves as a receptor for fluorescent HaloTag® ligands. Upon labeling with HaloTag® ligands (which form covalent, near-toundissociable bonds with the Halotag® receptor) and washing, the resulting fluorescent labeling is not influenced by de novo protein synthesis, therefore allowing for the specific monitoring of the fusion protein decline without any interference by protein synthesis. We demonstrate that a HaloTag®-p62 fusion protein stably expressed in suitable cell lines can be used to monitor autophagy by flow cytometry and automated fluorescence microscopy. We surmise that this system could be adapted to highthroughput applications. © 2011 Landes Bioscience.
引用
收藏
页码:883 / 891
页数:9
相关论文
共 50 条
  • [41] The role of p62/SQSTM1 in sporadic inclusion body myositis
    Nakano, Satoshi
    Oki, Mitsuaki
    Kusaka, Hirofumi
    NEUROMUSCULAR DISORDERS, 2017, 27 (04) : 363 - 369
  • [42] The PB1 and the ZZ domain of the autophagy receptor p62/SQSTM1 regulate the interaction of p62/SQSTM1 with the autophagosome protein LC3B
    Alcober-Boquet, Lucia
    Zang, Tabea
    Pietsch, Larissa
    Suess, Evelyn
    Hartmann, Markus
    Proschak, Ewgenij
    Gross, Lissy Z. F.
    Sacerdoti, Mariana
    Zeuzem, Stefan
    Rogov, Vladimir V.
    Leroux, Alejandro E.
    Piiper, Albrecht
    Biondi, Ricardo M.
    PROTEIN SCIENCE, 2024, 33 (01)
  • [43] p62/SQSTM1 and ALFY interact to facilitate the formation of p62 bodies/ALIS and their degradation by autophagy
    Clausen, Terje Hoyvarde
    Lamark, Trond
    Isakson, Pauline
    Finley, Kim
    Larsen, Kenneth Bowitz
    Brech, Andreas
    Overvatn, Aud
    Stenmark, Harald
    Bjorkoy, Geir
    Simonsen, Anne
    Johansen, Terje
    AUTOPHAGY, 2010, 6 (03) : 330 - 344
  • [44] Autophagy substrate SQSTM1/p62 regulates chromatin ubiquitination during the DNA damage response
    Wang, Yanan
    Zhu, Wei-Guo
    Zhao, Ying
    AUTOPHAGY, 2017, 13 (01) : 212 - 213
  • [45] Regulation of autophagic proteolysis by the N-recognin SQSTM1/p62 of the N-end rule pathway
    Cha-Molstad, Hyunjoo
    Lee, Su Hyun
    Kim, Jung Gi
    Sung, Ki Woon
    Hwang, Joonsung
    Shim, Sang Mi
    Ganipisetti, Srinivasrao
    McGuire, Terry
    Mook-Jung, Inhee
    Ciechanover, Aaron
    Xie, Xiang-Qun
    Kim, Bo Yeon
    Kwon, Yong Tae
    AUTOPHAGY, 2018, 14 (02) : 359 - 361
  • [46] Chloroquine blocks the autophagic process in cisplatin-resistant osteosarcoma cells by regulating the expression of p62/SQSTM1
    Shen, Chengchun
    Wang, Wenzhe
    Tao, Lijiang
    Liu, Bing
    Yang, Zhengming
    Tao, Huimin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2013, 32 (02) : 448 - 456
  • [47] p62/SQSTM1 in liver diseases: the usual suspect with multifarious identities
    Tan, Chong Teik
    Soh, Natalie Jun Hui
    Chang, Hao-Chun
    Yu, Victor C.
    FEBS JOURNAL, 2023, 290 (04) : 892 - 912
  • [48] An unexpected tumor suppressor role of SQSTM1/p62 in liver tumorigenesis
    Chao, Xiaojuan
    Ni, Hong-Min
    Ding, Wen-Xing
    AUTOPHAGY, 2022, 18 (02) : 459 - 461
  • [49] Hypoxia-activated autophagy accelerates degradation of SQSTM1/p62
    J-P Pursiheimo
    K Rantanen
    P T Heikkinen
    T Johansen
    P M Jaakkola
    Oncogene, 2009, 28 : 334 - 344
  • [50] AMPA Receptor Trafficking and Synaptic Plasticity Require SQSTM1/p62
    Jiang, Jianxiong
    Parameshwaran, Kodeeswaran
    Seibenhener, M. Lamar
    Kang, Myoung-Goo
    Suppiramaniam, Vishnu
    Huganir, Richard L.
    Diaz-Meco, Maria T.
    Wooten, Marie W.
    HIPPOCAMPUS, 2009, 19 (04) : 392 - 406